Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trial

A GogaTrisha RamrajLogashvari NaidooBrodie DanielsPenelope MooreNonhlanhla MkhizeE et al2025-01-222025-01-22WOS1471-2334https://hdl.handle.net/10539/43619Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing antiHIV1 monoclonal antibodies bNAbs given to HIV1 exposed uninfected neonates and infants study protocol for a phase I trialJournal Article